Vasodilators in VSDs.

Vasodilators in pulmonary hypertension.

Pulmonary vasodilators.

Pulmonary vasodilators are an important treatment for pulmonary arterial hypertension. They reduce pulmonary artery pressure; improve hemodynamic function; alter ventilation/perfusion matching in the lungs; and improve functional quality of life, exercise tolerance, and survival in patients with severe pulmonary arterial hypertension. This paper reviews the currently available pulmonary vasodil...

CLINICAL OUTCOME OF SMALL VENTRICULAR SEPTAL DEFECTS (VSDs) IN CHILDREN

Objective: To assess the clinical outcome of patients with isolated ventricular septal defects small enough not to require surgical closure. Methods: Between January 2001 and May 2003 a total of 118 patients who were recently or previously diagnosed to have isolated ventricular septal defects small enough not to require surgical closure were included in this study. Inclusion criteria for the st...

The VSDS environment based laboratory in computer architecture and organisation

Courses in computer architecture and organisation are indispensable part of any computer engineering curriculum. In most of cases these courses include the work in the laboratory with the aim to provide students not only with the theoretical background but also with some practical experience. The article presents an approach of achieving this using the originally developed VSDS environment. The...

Vasodilators in congestive heart failure.

1. Sarnoff SJ, Berglund E: Neurohemodynamics of pulmonary edema. IV. Effect of systemic vasoconstriction and subsequent vasodilation on flow and pressures in systemic and pulmonary vascular beds. Am J Physiol 170: 588, 1952 2. Imperial ES, Levy MN, Zieske H Jr: Outflow resistance as an independent determinant of cardiac performance. Circ Res 9: 1148, 1961 3. Sonnenblick EH, Downing SE: Afterloa...